Immunodominant PstS1 antigen of mycobacterium tuberculosis is a potent biological response modifier for the treatment of bladder cancer

por Sänger, Christian, Busche, Andreas, Bentien, Gabriele, Spallek, Ralf, Jonas, Fatima, Böhle, Andreas, Singh, Mahavir, Brandau, Sven
Publicado 2004

Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscleinvasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette- Guérin (BCG)...

por Witjes, J Alfred, Palou, Joan, Soloway, Mark, Lamm, Donald, Kamat, Ashish M, Brausi, Maurizio, Persad, Raj, Buckley, Roger, Colombel, Marc, Böhle, Andreas
Publicado 2013